US Stock MarketDetailed Quotes

INTS Intensity Therapeutics

Watchlist
  • 1.860
  • +0.110+6.29%
Close Jan 3 16:00 ET
28.09MMarket Cap-1.59P/E (TTM)

Intensity Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intensity Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Intensity Therapeutics Earnings Reports

  • Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 14, 2024 05:16

  • Intensity Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 05:03

  • Intensity Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9, 2024 04:43

  • Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 9, 2024 04:39

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data